Speciality: Endocrinology
Description:
A warm welcome to all the medical practitioners in this interesting session of biosimilar insulin Glargine.
Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.
The speakers Dr. Anoop Mishra and panel has provided an elaborative knowledge on biosimilar insulin Glargine in the management of diabetes in patients.
Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children. It is long-acting with the ability to control sugar all day long.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
2.
Clinical trial is testing whether heavy lifting could combat cancer side effects
3.
NIH research cuts leave cancer patient facing hard choice
4.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
5.
A video animation guide to assist young people who are fatigued from cancer.
1.
Hematology Drug Preparation Safety: Ensuring Efficacy and Reducing Risks in Clinical Practice
2.
The Latest Advances in Glioblastoma Treatment and Prevention
3.
AI-Assisted Real-Time Tumor Mapping During Surgery: Transforming Intraoperative Oncology
4.
Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology
5.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation